IMPURITIES AVAILABLE FOR 'Vonoprazan Fumarate'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Vonoprazan Fumarate. Vonoprazan Fumarate is a novel potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders such as GERD, peptic ulcers, and H. pylori eradication. It works by reversibly inhibiting the H⁺/K⁺-ATPase enzyme in gastric parietal cells, providing more potent and longer-lasting acid suppression than traditional PPIs. The fumarate salt form enhances stability, solubility, and formulation performance. Vonoprazan has a rapid onset of action, achieving significant acid suppression within hours of dosing. It is effective even in patients with PPI resistance or rapid CYP2C19 metabolism. The drug is well tolerated, with a favorable safety profile in both short- and long-term use. It is commonly used in combination with antibiotics for H. pylori therapy. Overall, Vonoprazan Fumarate represents a next-generation therapy for managing upper gastrointestinal acid disorders. Buy high quality Vonoprazan Fumarate from Omsynth Lifesciences.